INTRODUCTION
Microbial detection is emerging as a multistep process that ultimately requires direct contact between a host pattern-recognition receptor and a microbial molecule. A major issue in the field of innate immunity is to understand the microbial recognition process in tissues such as the gut where mechanisms to differentiate pathogenic infections from beneficial interactions with indigenous microbiota are essential. In this study, we analyzed the role of the six amidase peptidoglycan recognition proteins (PGRPs) of Drosophila that are predicted to influence bacterial sensing by their capacity to scavenge peptidoglycan.
Peptidoglycan is a highly complex and essential component of the cell wall of virtually all bacteria. It consists of long glycan chains made of alternating N-acetylglucosamine and N-acetylmuramic acid (MurNAc) residues that are crosslinked to each other by short peptide bridges (Chaput and Boneca, 2007) .
Peptidoglycan from Gram-negative bacteria differs from most Gram-positive peptidoglycan by the replacement of lysine with meso-diaminopimelic acid (DAP) at the third position in the peptide chain. The polymeric nature of peptidoglycan, as well as its diversity, makes this molecule a unique signature for the host to detect and even differentiate different types of bacteria. Pattern-recognition receptors involved in the recognition of peptidoglycan include PGRPs in insects and NODs in mammals (Royet and Dziarski, 2007) . Interestingly, the peptidoglycan polymer can also be processed and degraded by several host enzymes, namely lysozymes and amidase PGRPs, thereby indirectly influencing bacterial sensing by pattern-recognition receptors. The most diverse functional family of peptidoglycaninteracting proteins are the PGRPs that have recently been implicated in the dialogue between microbes and their host in several symbiotic and pathogenic interactions (Anselme et al., 2006; Dziarski and Gupta, 2010; Li et al., 2007; Royet and Dziarski, 2007; Troll et al., 2010; Wang et al., 2009; Yu et al., 2010) .
PGRPs are highly conserved from insects to mammals and share a conserved 160 amino acid domain with similarities to the bacteriophage T7 lysozyme, a zinc-dependant amidase that hydrolyzes peptidoglycan (Royet and Dziarski, 2007) . Like T7 lysozyme, some PGRPs, referred to as catalytic PGRPs, hydrolyze peptidoglycan by cleaving the amide bond between MurNAc and the peptidic bridge. In contrast, noncatalytic PGRPs bind to peptidoglycan but lack amidase activity because of the absence of key cysteine residues for zinc binding. Noncatalytic PGRPs are crucial for the sensing of bacteria in insects such as Drosophila. The Drosophila genome encodes seven noncatalytic PGRPs, four of which (PGRP-SA, -SD, -LC, and -LE) mediate bacterial sensing upstream of the Toll and Imd pathways that regulate the production of antimicrobial peptides (AMPs) (Ferrandon et al., 2007) . PGRP-SA and PGRP-SD are secreted proteins circulating in the hemolymph that have been shown to activate the Toll pathway in response to the lysine-type peptidoglycan found in most Gram-positive bacteria (Royet and Dziarski, 2007) . PGRP-LC acts as a transmembrane receptor upstream of the Imd pathway and is activated by the DAP-type peptidoglycan of Gram-negative bacteria or Bacillus (Royet and Dziarski, 2007) . Recent studies indicate that both polymeric and monomeric Gram-negative peptidoglycan mediate Imd pathway activation via various PGRP-LC isoforms (Kaneko et al., 2004; Stenbak et al., 2004) . Finally, PGRP-LE, a secreted PGRP that binds preferentially to DAP-type peptidoglycan, functions synergistically with PGRP-LC in both autophagy and Imd pathway activation (Ferrandon et al., 2007; Yano et al., 2008) . The Drosophila genome also encodes six catalytic PGRPs (PGRP-SC1A, -SC1B, -SC2, -LB, -SB1, and -SB2) that have been less studied. The predicted catalytic activity of amidase PGRPs led to the proposal that they might either modulate the immune response by scavenging peptidoglycan or act as directly antibacterial agents (Mellroth et al., 2003) . This catalytic activity has been demonstrated for PGRP-LB, PGRP-SC1B, and PGRP-SB1 (Mellroth et al., 2003; Mellroth and Steiner, 2006; Zaidman-Ré my et al., 2006; Zaidman-Ré my et al., 2011) . In the case of PGRP-SC1B and PGRP-LB, this enzymatic activity was shown to be required for their capacity to downregulate the immune response (Mellroth et al., 2003; Mellroth and Steiner, 2006; Zaidman-Ré my et al., 2006; Zaidman-Ré my et al., 2011) . Various studies have addressed the in vivo roles of these proteins through RNAi or single mutations. In spite of these studies, no clear picture of the overall role of the amidase PGRPs has emerged, with a role for PGRP-LB in regulation of the Imd pathway (Zaidman-Ré my et al., 2006) , conflicting evidence for roles of PGRP-SCs (PGRP-SC1A, -1B, and -SC2) in regulation of the Imd and Toll pathways and of phagocytosis of Gram-positive bacteria (Bischoff et al., 2006; Garver et al., 2006) , and thus far no overt phenotype in flies deleted for PGRP-SB1 and SB2 (Zaidman-Ré my et al., 2011) . In this study, we have generated Drosophila lines deleted for PGRP-LB and the PGRP-SC1A, -SC1B, and -SC2 gene cluster by homologous recombination. By analyzing these mutations singly and in combination, we clarify the functions of this class of PGRPs in the fine-tuning of the Drosophila immune response.
RESULTS
A Gene-Deletion Strategy to Address Amidase PGRP Function Through homologous recombination, we previously obtained a deletion of PGRP-SB1 and PGRP-SB2 (referred to as PGRP-SB D ), which showed no immune phenotype and gave no clues as to the function of these two genes (Zaidman-Ré my et al., 2011) . This raised the possibility of functional redundancy among the amidase PGRPs. In this study, we have generated further mutant lines deleted for either PGRP-LB (referred to as PGRP-LB Figure 1A ). In contrast to the PGRP-LB RNAi phenotype, this Dpt expression was maintained in PGRP-LB D until 2 days post-infection and then declined by 4 days post-infection. An enhanced immune response was also observed when flies were infected with another Gram-negative bacterium, Enterobacter cloacae ( Figure S2A , left graph). The same phenotype, albeit with more rapid kinetics, was observed after injection of inert DAP-type peptidoglycan, confirming that the increase in immune response was a result of increased stimulation of Imd signaling and not of increased bacterial proliferation (Figures 1B and S2A, middle graph expressed Dpt-lacZ to a much higher level in the cardia and midgut than the wild-type control ( Figure 2A , right panel). This observation was also borne out by quantification of the endogenous Dpt transcript ( Figure 2B ). A principal role for amidase PGRPs in the gut could be to prevent unnecessary immune responses to commensal microbiota. Indeed Ryu et al. (2008) showed that the basal expression of PGRP-LB in the adult midgut is lost in germ-free conditions, suggesting that it is induced in the presence of microbiota to prevent an Imd pathway response. This role was confirmed by the observation that PGRP-LB D guts showed substantially higher Dpt-lacZ expression than the wild-type control in the absence of any infection ( Figure 2A , left panel). Furthermore, in germ-free conditions, this Dpt-lacZ expression was reduced, demonstrating that it reflects an unsuppressed immune response to microbiota (Figure 2A , left panel).
PGRP-LB Prevents Systemic Immune Activation after Ingestion of Bacteria
Oral infection with certain Gram-negative bacteria, including Pseudomonas entomophila, leads not only to a local but also a systemic fat body immune response (Vodovar et al., 2005) . It has been proposed that this systemic reaction to a local infection is mediated by translocation of peptidoglycan fragments across the gut epithelium (Gendrin et al., 2009; Zaidman-Ré my et al., 2006) . This was supported by the observation that PGRP-LB RNAi flies with reduced amidase activity showed a systemic immune response to oral infection with Ecc15, which induced no systemic response in wild-type flies. PGRP-LB D mutant flies likewise showed a strong response to oral Ecc15 infection to a level similar to that observed after infection by septic injury with the same bacteria ( Figure 3A ). suppressed by overexpression of PGRP-LB in the gut (NP1-Gal4), in the fat body and hemocytes (C564-Gal4), or ubiquitously (da-Gal4) ( Figure 3C ). Thus, our study confirmed that PGRP-LB is a negative regulator of the Imd pathway response in both epithelia and the fat body of adults and larvae (Supplemental Results and Figure S3 ). Members of the PGRP-SC family are strongly expressed in the gut of adult flies and induced there upon oral infection with Ecc15 (Buchon et al., 2009b; Werner et al., 2000 showed no systemic response to oral infection with Ecc15 (Figure 3A) . Thus, the PGRP-SC family does not appear to have a major role in the regulation of the gut immune response of adult flies or in the systemic response to gut infections. In contrast to the Bischoff et al. (2006) study, which used an RNAi approach, we did not uncover any major role for the PGRP-SC family in the regulation of the gut immune response in adults nor in the systemic response to gut infections at the larval stage (Supplemental Results and Figure S3 ). increased Dpt expression at 12 and 24 hr postinfection, reflecting the importance of both PGRPs in the regulation of this response ( Figure 1A) . Strikingly, the Dpt expression remained higher in PGRP-SC D ;LB D flies at 2 and 4 days postinfection than the peak Dpt expression in wild-type flies. As with the single-mutant strains, this increased response did not reflect an increased bacterial load given that no early susceptibility to infection was observed ( Figure S2B , top graph) and a similar increase and extension of the immune response was seen after injection of DAP-type peptidoglycan ( Figures 1B and S2A , middle graph). In contrast to the response to septic injury, no striking effect of PGRP-SC D was observed on the response to oral infections.
In agreement, PGRP-SC D ;LB D guts showed only a modest (C) The use of ubiquitous (da-Gal4), fat body (C564-Gal4) and gut (NP1-Gal4) Gal4 drivers show that expression of PGRP-LB in the whole body, gut, or fat body and hemocytes is sufficient to block the systemic immune response 1 day after oral infection with Ecc15. A cross indicates that data could not be analyzed because many of the flies were dead at this time point. Data are representative of at least three independent experiments (mean + SEM). *p < 0.05 and **p < 0.01 with a Student's t test.
increase in Dpt expression over PGRP-LB D guts in both Ecc15
infection and unchallenged conditions ( Figure 2B ). Figure 2B ) and systemically ( Figure 3A ). Figure 2B ) and much higher and more persistent expression systemically ( Figure 3A ) than are ever observed in wild-type flies with standard modes of infection. Figure S5A ). Of note, we did not see any translocation of Ecc15 from the gut lumen to the hemolymph in the triple mutant flies (data not shown). Furthermore, these flies were also susceptible to oral infection with dead sonicated Ecc15 ( Figure 5B ), demonstrating that it is not bacteria that are killing the fly but rather its own excessive immune response. Figure 5A with Figure 5B ;LB flies had substantially longer life spans than their conventionally raised counterparts ( Figure 5C ). Table S1 .
Lack of Negative Imd Pathway Regulation in Amidase
activities of intestinal stem cells and fly health (Biteau et al., 2010; Buchon et al., 2009a flies, it was plausible to consider that a lack of negative Imd regulation could lead to cell death and increased epithelium renewal. To test this hypothesis, we stained guts with an anti-phosphohistone H3 (anti-PH3) antibody that marks dividing stem cells. As previously reported, a low number of PH3-positive cells were detected in the gut of unchallenged wild-type flies while the number of mitotic cells increased upon Ecc15 infection, indicative of higher epithelium renewal ( Figure 6A) (Buchon et al., 2009a; Jiang et al., 2009 (Figures 6B and 6C ). The presence of the Dredd mutation fully suppressed both the high mitotic count ( Figure 6A ) and the elevated JAK-STAT activity ( Figures 6B and  6C ) observed in pirk EY ,PGRP-SC D ;LB D flies in the absence of infection, demonstrating that excessive Imd pathway activation is required for the gut damage which leads to epithelium renewal in these flies. We concluded that tight control of Imd pathway activity by amidase PGRPs and Pirk prevents the chronic and deleterious stimulation of intestinal stem cell activity by microbiota and ingested bacteria.
DISCUSSION
In this study, we performed a systematic analysis of amidase PGRP function in Drosophila. Using three independent deletions, we were able to remove the three amidase PGRP families. Previous studies using an RNAi approach have suggested that PGRP-LB and the PGRP-SC family are required for fly viability (Bischoff et al., 2006; Zaidman-Ré my et al., 2006) . In contrast, the use of null mutation lines reveals that PGRP-LB D and SC D flies are viable under laboratory conditions. Furthermore, we were surprised to find that viable flies lacking the whole set of amidase PGRPs could be obtained, albeit at lower frequency than expected. This indicates that amidase PGRPs do not play any essential role in Drosophila development. The first aim of our project was to clarify the respective roles of PGRP-LB and the PGRP-SC family in the immune response. Our study confirms that PGRP-LB negatively regulates the Imd pathway both in barrier epithelia and in the fat body in agreement Zaidman-Ré my et al. (2006) . Our present study uncovers a new role of PGRP-LB in downregulating the Imd pathway in the adult gut by commensals under unchallenged conditions. PGRP-SC1 and -SC2 has been reported to have conflicting roles in regulation of the Imd and Toll pathways and in the phagocytosis of Gram-positive bacteria (Bischoff et al., 2006; Garver et al., 2006) . The use of this deletion reveals a narrower role for this family of PGRP. Indeed, we observed no major impact of the PGRP-SC deletion on the activity of either the Toll pathway or local Imd pathway activity in response to oral infection, in contrast with previous studies. Our study reveals instead that the PGRP-SC family negatively regulates the Imd pathway during systemic infection and synergizes with PGRP-LB and Pirk in the systemic immune response to ingested bacteria. We have not addressed the individual contribution of each of the three PGRP-SC isoforms, PGRP-SC1A, PGRP-SC1B, and PGRP-SC2, to these phenotypes. PGRP-SC1A and PGRP-SC1B have probably arisen from a recent duplication given that the two genes differ only by a synonymous mutation, and because their expression is confined to the gut it seems likely that PGRP-SC2 might be responsible for the higher immune activation during systemic infection. Our studies leave open the possibility that PGRP-SC1A and -SC1B have additional functions in the gut such as the digestion of peptidoglycan or regulation of commensals.
The observation that the contribution of the PGRP-SC family to the local immune response is largely masked by PGRP-LB is intriguing. The phenotype observed could be explained if PGRP-LB were capable of fully processing ingested peptidoglycan while the PGRP-SC family members had a lower activity because of a more restricted expression pattern and/or different enzymatic properties. Biochemical studies on PGRP-LB, PGRP-SB1, and to a lesser extent the PGRP-SC family indicate that amidase PGRPs differ in their enzymatic efficiencies and substrate specificities (Mellroth et al., 2003; Zaidman-Ré my et al., 2006; Zaidman-Ré my et al., 2011) . Further studies should explore the enzymatic characteristics of PGRP-SC1A, SC1B, and PGRP-SC2. Nevertheless, it is possible that PGRP-SC has additional independent functions that may be revealed by the use of specific bacterial strains.
The involvement of several amidase PGRPs in the downregulation of the Imd pathway is interesting. Experimental and modeling analyses have suggested that one advantage of multiple layers of negative regulation is to reduce the noise inherent in the system, by limiting oscillation of signaling activity (Mengel et al., 2010) . Thus, the involvement of multiple amidase PGRPs in the control of Imd signaling would reinforce the tight control of this pathway and make it less sensitive to variation. Moreover, differences in the expression pattern of amidase PGRPs in different gut regions, along with the superimposition of inducible and constitutive levels of expression, will add to the precise patterning of the spatial and temporal activity of the Imd pathway in this tissue.
Finally, our study did not reveal any cryptic phenotype for PGRP-SB1 and SB2 in combination with the PGRP-SC and/or LB gene deletion. We can conclude that PGRP-SB1 and SB2 are, at most, only marginally involved in the regulation of the Imd pathway. The observation that PGRP-SB1 is induced to high levels after infection, with an expression level similar to that of antimicrobial peptide genes, and that PGRP-SB2 is also strongly induced during metamorphosis point to a putative role as immune effectors as described for zebrafish amidase PGRPs . This function might be masked by the plethora of other immune effectors present in the genome of Drosophila (see discussion in Zaidman-Ré my et al., 2011) .
Our study reveals that both Pirk, which reduces the level of Imd signaling downstream of PGRP-LC, and amidase PGRPs (LB and SC), which limit the availability of PGRP-LC ligand, synergize to dampen the immune response. Although flies lacking A B C one, or even two, of these negative regulators exhibit higher immune responses, the level of immune activity declines at late time points, indicating that they still possess some regulatory capacities. In sharp contrast, removing both amidases (PGRPSCs and PGRP-LB) as well as Pirk leads to uncontrolled immune responses. The level of immune response in infected flies does not peak and then decline, but remains extremely high at 4 days after infection, after which the flies die rapidly as a result of their excessive immune response.
In Drosophila, bacterial infection triggers a massive expression of antimicrobial peptide genes, which are among the most highly expressed genes in the genome. Thus, we were surprised to find that removing Pirk, PGRP-LB, and the PGRP-SCs can still lead to AMP expression levels eight to ten times higher than those observed during infections of wild-type flies. This indicates that the immune response is highly constrained by the existence of negative regulators. The observation that the extent of the immune response to severe infections is far below the maximum possible response is intriguing and highlights the importance of negative regulation in shaping the antibacterial response.
The tight constraints on the level of Imd signaling suggest a strong selection to limit the antibacterial response, but previous studies have not addressed the relevance of amidase PGRPs and/or Pirk to the fitness of flies. Indeed, taking into account possible background effects, the fitness outcome of deleting a single negative regulator is modest. flies shows that this higher immune response and lethality result from an excessive immune response rather than a change in microbiota composition. Strikingly, this effect was largely suppressed by blocking the activity of the Imd pathway. In conclusion, our study highlights the importance of tight regulation of the Imd pathway by the amidase PGRPs and Pirk to prevent excessive immune responses to innocuous bacteria and basal activation by commensals, which reduce lifespans. Several studies have shown that low intestinal stem cell activity is a good indicator of gut homeostasis (Biteau et al., 2010; Buchon et al., 2009a) . For instance, old flies show abnormal gut morphology due to higher proliferation of stem cells and their aberrant differentiation (Choi et al., 2008) . Biteau et al. (2010) PGRPs are highly conserved from insects to mammals. Mammals have four PGRPs: three of them, PGLYRP1, PGLYRP3, and PGLYRP4, are directly bactericidal, whereas PGLYRP2 is an amidase that hydrolyzes peptidoglycan (Gelius et al., 2003; Lu et al., 2006; Wang et al., 2007) . Although both mammalian and insect PGRPs are involved in the host response to infection, they have distinct roles. In insects, PGRPs are mostly involved in activating or downregulating defense pathways after microbial sensing (Royet and Dziarski, 2007) . By contrast, mammalian PGRPs have primarily antimicrobial activities. Interestingly, all four mammalian PGRPs have recently been implicated in protecting the host from colitis induced by dextran sulfate sodium (DSS) (Saha et al., 2010) . Mice deleted for each of the PGLYRP genes were all shown to be more sensitive than wild-type mice to DSS-induced colitis because of the presence of a more inflammatory gut microbiota, higher production of interferon-g, and an increased number of NK cells in the colon. Together with our paper, this recent finding uncovers a conserved role of PGRPs in the maintenance of proper gut homeostasis by inhibiting the immune response induced by commensals or innocuous ingested bacteria. This goal is accomplished, however, by different strategies. Drosophila PGRPs (LB and the SC family) reduce Imd pathway activation by reducing the biological activity of peptidoglycan, whereas mammalian PGRPs seem to have a direct effect on the microflora composition.
Collectively, our study and others underline the multiple roles of PGRPs in the Drosophila immune response as patternrecognition receptors, negative regulators, and potentially bactericidal molecules. The Drosophila genome encodes 26 genes (13 PGRPs and 13 lysozymes) with the potential to detect and/or lyse peptidoglycan and consequently modulate the relationship between Drosophila and bacteria. To date, Drosophila lysozymes have only been proposed to be involved in the digestion process, on the basis of their strong expression in the gut (Daffre et al., 1994) , although a role in modulation of the immune response is not excluded. The fact that PGRPs are key players in the Drosophila immune response raises some questions regarding their emergence as pattern-recognition receptors during evolution. A possible scenario would be that catalytic PGRPs emerged first as digestive and/or antibacterial enzymes participating in the elimination and utilization of ingested bacteria, in synergy with lysozymes. Noncatalytic PGRPs may then have been selected for bacterial sensing, whereas some catalytic PGRPs (such as PGRP-LB and the PGRP-SCs) might have differentiated into modulators of the immune response. Diversification of the PGRP domain to allow it to distinguish between DAP-versus Lys-type peptidoglycan and monomeric versus polymeric peptidoglycan, because of its capacity to sense the peptidic-glycan bridge of peptidoglycan, has probably allowed PGRPs to adopt a broad range of functions in the insect immune system. Future studies should investigate the possibilities that amidase PGRPs also play a role in the digestive process and lysozymes in the modulation of the immune response. 
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